UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2025
Commission file number: 001-42389
BIOHARVEST SCIENCES INC.
(Exact name of Registrant as specified in its charter)
Not applicable
(Translation of Registrant’s name into English)
1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
☐ Form 20-F ☒ Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SUBMITTED HEREWITH
[Exhibits: Exhibit Description99.1Material Change Report dated August 14, 2025]()
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: August 14, 2025*/s/ David Ryan* Name: David Ryan Title: Vice-President, Investor Relations & Secretary
Material Change Report dated August 14, 2025 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company BIOHARVEST SCIENCES INC. Suite 1140 – 625 Howe Street Vancouver, BC, V6C 2T6 (the “Company” or “BioHarvest”) Item 2. Date of Material Change August 13, 2025. Item 3. News Release The news release (the “News Release”) was issued on August 13, 2025 and disseminated by Stockwatch. Item 4. Summary of Material Change The Company announced that the board of directors has adopted an amended insider trading policy. Item 5. Full Description of Material Change The Company announced that the board of directors has adopted an amended insider trading policy (the “Amended Insider Trading Policy”) to make the trading window a more reasonable period of time. The trading window under the Amended Insider Trading Policy opens after the close of trading on the second full trading day following the widespread public release of our quarterly or year-end operating results and closes fifteen (15) calendar days before the due date (which date does not include any available extension periods) of any of the Company’s quarterly or year-end operating results. Item 6. Reliance on Subsection 7.1(2) of National Instrument 51-102 Not applicable. Item 7. Omitted Information None. Item 8. Executive Officer For further information, please contact: David Ryan Secretary and VP, Investor Relations 604 622-1187 Item 9. Date of Report August 14, 2025.
